Skip to main content
. 2015 Dec 16;15:953. doi: 10.1186/s12885-015-1989-z

Table 2.

Detection of CK20 positive tumor cells (CTC) in the blood of patients with rectal cancer

Variable Category Rate of CK20 positive CTC χ2-test (p-values)
Neoadjuvant RCTX Yes 46.8 % (37/79) p = 0.002
No 24.7 % (43/174)
Tumor localisation Upper 1/3 31 % (27/87) p = 0.42
Middle 1/3 27.6 % (29/105)
Lower 1/3 37 % (23/61)
pN- status pN+ 30 % (31/103) p = 0.6
pN- 32.6 % (49/150)
UICC stage I 30.6 % (23/75) p = 0.99
II 32.3 % (23/71)
III 31.3 % (25/80)
IV 33.3 % (9/27)